These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS. Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179 [TBL] [Abstract][Full Text] [Related]
12. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis. Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005 [TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239 [TBL] [Abstract][Full Text] [Related]
14. Diffusely appearing white matter in multiple sclerosis: Insights from sodium ( Weber CE; Nagel K; Ebert A; Roßmanith C; Paschke N; Adlung A; Platten M; Schad LR; Gass A; Eisele P Mult Scler Relat Disord; 2021 Apr; 49():102752. PubMed ID: 33486402 [TBL] [Abstract][Full Text] [Related]
15. Multicontrast connectometry: a new tool to assess cerebellum alterations in early relapsing-remitting multiple sclerosis. Romascano D; Meskaldji DE; Bonnier G; Simioni S; Rotzinger D; Lin YC; Menegaz G; Roche A; Schluep M; Pasquier RD; Richiardi J; Van De Ville D; Daducci A; Sumpf T; Fraham J; Thiran JP; Krueger G; Granziera C Hum Brain Mapp; 2015 Apr; 36(4):1609-19. PubMed ID: 25421928 [TBL] [Abstract][Full Text] [Related]
16. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. Griffin CM; Chard DT; Parker GJ; Barker GJ; Thompson AJ; Miller DH J Neurol; 2002 Feb; 249(2):193-9. PubMed ID: 11985386 [TBL] [Abstract][Full Text] [Related]
17. Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study. Jakimovski D; Ramanathan M; Weinstock-Guttman B; Bergsland N; Ramasamay DP; Carl E; Dwyer MG; Zivadinov R Mult Scler; 2020 Mar; 26(3):322-332. PubMed ID: 30755085 [TBL] [Abstract][Full Text] [Related]
18. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis. Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543 [TBL] [Abstract][Full Text] [Related]
19. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. Mesaros S; Rocca M; Sormani M; Valsasina P; Markowitz C; De Stefano N; Montalban X; Barkhof F; Ranjeva J; Sailer M; Kappos L; Comi G; Filippi M Mult Scler; 2010 Mar; 16(3):325-31. PubMed ID: 20086023 [TBL] [Abstract][Full Text] [Related]
20. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis. Maranzano J; Dadar M; Zhernovaia M; Arnold DL; Collins DL; Narayanan S Neuroimage; 2020 Jun; 213():116690. PubMed ID: 32119987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]